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Abstract
The ovulation is a complex physiological process which is very commonly 
affected in patients with PCOS. Understanding inflammatory process involved in 
ovulation is important with respect to its onset, diagnosis and treatment. There are 
multiple inflammatory factors are associated with ovulation however anovulation 
and contraception have not been therapeutically explored in context with inflam-
matory process. Therefore, this chapter is written to help readers to understand the 
basics of inflammation in ovulation and role of inflammatory mediators in ovula-
tion. This chapter also describes genetic and molecular aspects linked to ovulation.
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1. Introduction
Mammalian ovulation is a fundamental physiological process involves the 
rupturing of follicle and releasing of the dominant follicle from the ovary into the 
fallopian tube where it has the potential to get fertilized if it exposed to sperm. 
Oocyte is covered up of four different layers namely the granulosa cells, which form 
a protected layer within oocyte and the extra follicular microenvironment, then 
theca layers of theca-interna and theca-externa, tunica albuginea and the outermost 
one is epithelium [1, 2]. A thin transparent layer between oocyte and follicular 
membrane is made up of secretions by the oocyte, termed as zona pellucida [2].
The developing oocyte enclosed in a ovarian follicle which is float in a dynamic 
fluid i.e. Follicular fluid (FF), contain variety of signaling molecules such as poly-
saccharides, hormones, cytokines, chemokines, growth factors, reactive oxygen 
species (ROS), metabolites, antioxidant enzymes, etc. The follicular fluid formed in 
developing antral follicles, primarily to support the development and protection of 
oocytes. These molecules are also acts as communicators between somatic and germ 
cells [3].
The duration of ovulatory process in humans, pigs, rats and rabbits takes 
approximately 40, 22, 12 and 10 hours respectively to complete. Substantial tissue 
remodeling occurs during the ovulation, the follicle increases its own size, and 
the layers of theca cells fuse with the tunica albuginea, resulting into thinner and 
permitting rupturing of follicle to release the oocyte [4]. The mature oocyte when 
released by the rupturing of follicle its uptake facilitated by the fingure like opening 
projections of fallopian tube which is known as fimbriae, if fertilization occur here 
then the blastocyst further transfer it towards the uterus where the pregnancy takes 
place [5].
Inflammation is defensive mechanism of the cells that is crucial to health and 
it is delineated as a local immune response of living vascularized tissues to endog-
enous and exogenous stimuli and its actions is to removal of injurious stimuli with 
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starting the healing process [6]. Inflammation is also initiated when the cells die 
from deficiency of nutrients or hypoxia, a condition that often is originated by the 
blood flow loss to the site. The chemical mediators of the inflammation generally 
originate from the blood plasma, platelets, white blood cells (monocytes, neutro-
phils, basophils, and macrophages), endothelial cells lining of the blood vessels, 
mast cells, and injured tissue cells. The chemical mediators responsible for the 
inflammation is histamine, that stimulates vasodilation and increases the vascular 
permeability, and lysosomal substances acting as vascular permeability enhancer 
which are secreted from neutrophils, and certain small proteins in the complement 
system, namely C3a and C5a. Various cytokines released by inflammatory cells 
also have vasoactive and chemotactic function. Many cells produce prostaglandins 
which linked to the fever and pain of inflammation; a group of fatty acids which 
involves in the augmentation of vascular permeability of the other substances, 
platelets aggregation; which is essential for coagulation [6].
The objective of this review is to understand and establish a relationship 
between how the inflammation as well as different mediators of inflammation 
that influence the ovulation process that is crucial for clinical management and 
prediction of gynecological complications for future study.
2. Inflammatory genetic mechanism
Inflammation is detected throughout many normal reproductive progressions, 
for the duration of ovulation, menstruation, implantation, as well as parturi-
tion. Ovulatory cycle is also considered as inflammatory process because the 
rupturing of dominant follicle undergoes the process of healing [7]. Throughout 
ovulation, the role of inflammation is very significant in terms of folliculogenesis 
and luteinization. In the course of the rupturing of follicle, there is significant 
surge of intra-follicular pressure which leads to weakening of follicle layer by the 
stimulation of gonadotropins resulted in inflammation [8]. The inflammation 
notably persuades in both ovulation and tissue remodeling phase which resulted 
in events of hyperemia, vasodilation, edema, collagenolysis, and proliferation of 
cells [1].
Wissing et al. isolated differentially expressed 1186 genes in human granulosa 
cells (GC) before and 36 h after the administration of hCG, besides 572 genes found 
to be up-regulated which represented angiogenesis, inflammation, extracellular 
matrix and growth factors and 614 genes down-regulated which denoted cell cycle 
and about 72 genes which has been earlier establish linked with ovarian cancer. 
H19/mir675, CD24, CLDN11, ANKRD22, and FBXO32 adds as new ovulation 
related genes and PTGS2, an inflammatory gene heavily up-regulated [5].
3. Inflammatory oxygen species and ovulation
The release of mature oocyte relies on the expansion of cumulus oocyte complex 
(COC), where the reactive oxygen species (ROS) function as critical modulator 
of inflammatory reaction. Residual growing follicles promoted to apoptosis by 
the ROS [8]. Simultaneously estrogen synthesis started with the influx of catalase 
and Glutathione (GSH) i.e. a non-enzymatic antioxidant species exists in oocytes 
and embryos, in growing residual follicles for the maintenance of normal ovarian 
function and counter the apoptotic process. The luteal phase begins with pro-
gesterone production for the maintenance of preliminary stage of pregnancy, if 
fertilization did not occur then degeneration of corpus luteum starts [2]. For the 
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induction of cell proliferation, maturation, cellular-differentiation and ovulation 
the physiological level of ROS is very important [9]. Augmented ROS may outcomes 
to DNA damage, activation of signaling cascades, and epigenetic alterations [10]. 
Inflammation in the course of ovulation is also responsible for the oxidative stress, 
damaging of DNA and moreover in the neoplastic ovarian surface epithelium (OSE) 
cells transformation [11].
4. PCOS and inflammation
Elevated level of inflammation also involves in the pathogenicity of many 
reproductive disorder such as polycystic ovary syndrome (PCOS), characterized 
by biochemical hyperandrogenemia, chronic anovulation, and polycystic ovaries. 
About 5 to 15% of reproductive age woman are suffering with this disorder in the 
world. It is anticipated that the metabolic disorders associated with PCOS and the 
pathogenesis of PCOS due to systemic inflammation as well as dysfunctioning 
of mitochondria. About 33% adolescent PCOS girls are more prone to metabolic 
disorder are obese, which is 3 to 5 folds higher if compared with same age healthy 
girls and body mass index (BMI) [9]. Studies reported and found the significant 
increased level of monocytes, lymphocytes, CRP, interleukins IL-1, IL-6, IL-18, 
pro-inflammatory cytokines and TNF- α in addition to increased production of 
advanced oxidation protein, protein carbonylation and lipid peroxidation in PCOS 
patients compared with same reproductive aged healthy persons [9]. The PCOS 
patients suffered with chronic inflammation [12, 13]. Along with the deficiency 
of antioxidant i.e. Vitamin C, Vitamin E and Superoxide dismutases (SOD), this 
leads to cause inflammatory milieu and risk to develop the obesity, type-1 diabetes, 
insulin resistance, hyperandrogenism, and cardiovascular ailment [1, 14].
5. Anti-inflammatory agents and ovulation
The surge of luteinizing hormone (LH) stimulate the production of cyclic 
adenosine monophosphate (cAMP), steroidal hormones, histamine discharge and 
various mediators of inflammation e.g. prostaglandins, bradykinins, C-reactive 
protein (CRP), Proinflammatory cytokines, etc. [1]. Christina et al. study states that 
the successful folliculogenesis, oocyte maturation, and ovulation require a healthy 
inflammatory response.
There are many findings illustrate that the importance of untroubled inflam-
matory response for proper folliculogenesis and ovulation, if it altered, may 
contribute to oocyte quality concern and reproductive dysfunctions such as 
anovulation, infertility, menstrual irregularities, etc. [5, 8]. It is reported that low 
dose of Aspirin taken by the patients suffering with higher systemic inflammation 
were able to reestablish the pregnancy [4, 12].
6. Correlation between hormone and inflammation
The level of LH also positive correlation with release of prostaglandins and 
eicosanoids that are the source to trigger the fibroblasts, promotes the angiogenesis 
and hyperemia, collagenase activation, release of proteolytic enzymes, some of 
which degrade the follicular connective tissue resulting ovulation, and cause the 
inflammation. The gene hyaluronan (HA) synthase-2 (Has2) associated with COC 
matrix formation. Bradykinin play a key role in vasodilation which appears to be 10 
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folds increased during ovulation. The serum C- reactive protein (CRP), a marker of 
inflammation also raised to stimulate the production of interlukin-6 from macro-
phages, tumor necrosis factor α (TNFα) and the competent system of inflammatory 
response further activated by the adipocytes [13].
7. Role of proinflammatory cytokines
The role of proinflammatory cytokines is also important throughout folliculo-
genesis and induction of ovulation [5]. Higher level of follicular TNF-α resulted in 
the poor quality of oocyte which compromised with the fertility, also the elevated 
level of interleukin (IL-6) associated with less chances of conceiving while the 
another interleukin (IL-1) found to be regulated by FSH and its higher follicular 
level has been resulted in the higher chance on embryo implantation [7, 15].
8. Nucleotide leukin rich polypeptide -3 inflammasomes
A recent finding added a new mechanism for ovulatory process regulation, 
suggested that the NLRP3 activation of nucleotide leukin rich polypeptide 3 
(NLRP3) inflammasomes started before the ovulation lasting completion of 
ovulation. They induces the follicular development by 52 hours’ treatment using 
Pregnant mare serum gonadotropin (PMSG). It was found that the expression 
of NLRP3 inflammasomes and adaptor protein apoptosis-associated speck-like 
protein (ASC) significantly increased, and it was appeared a dramatic surge in 
caspase-1 activity and production of IL-1β [16].
9. Gonadotropin in inflammation
Gonadotropin surge trigger the ovlation with the parllel stimulation of two 
gens of preovulatory follicles in granulosa cells, prostaglandin-endoperoxide 
synthase 2 (PTGS2) and progesterone receptor (PGR). Secretion of LH stimulates 
the induction of both PTGS2 and PGR in preovulatory granulosa cells. Expression 
of PTGS2 stimulates inflammation by releasing pro-inflammatory prostaglandins 
wheras anti-inflammatory action through the PGR by the supression of pro-
inflamatory genes or thru the stimulation of antiinflammatory genes. Higher level 
of PGE2 and PTGS2 are associated with the ovarian disorders such as ovarian 
carcinoma, ovarian hyperstimulation syndrome (OHSS) as well as polycystic ovar-
ian syndrome (PCOS) [11].
10. Inflammatory prostaglandins
Prostaglandins (PGs) are signaling molecules derived from dietary fats with 
clinically relevant roles in reproductive biology. PGE2, for instance, promotes 
ovulation downstream of the luteinizing hormone surge. Excess consumption of 
nonsteroidal anti-inflammatory drugs, which inhibit prostaglandin-endoperoxide 
synthase (cyclooxygenase or Cox), is associated with reversible female infertil-
ity, likely due to failed ovulation. On the other hand, proinflammatory cytokines 





A study (Bongrani et, al.) based on the adipokines roles in the pathophysiology 
of PCOS, they analyzed the adipokines profile in the normal-weight PCOS patients 
and obese women with PCOS and comparison of these with the women whose only 
have a Polycystic ovary morphology. Whereas they found the PCOS patient reported 
with lower adiponectin level in serum as well as FF, and also the lower expression in 
adipose tissue of AdipoR1 and AdipoR2. In granulosa cells AdipoR1 expression was 
positively correlated with the follicular numbers, oocytes count and embryos, on the 
other hand there was no significant difference in AdipoR2 reporters was found. No 
correlation was established among the FF adiponectin concentration and expres-
sion of its receptor, AdipoR1/AdipoR2 in GCs. Dysregulation of adiponectin may be 
likely mechanisms which could be responsible for impairment of insulin-sensitivity 
in PCOS patient, and it seems to be independent of insulin resistance severity and a 
potential role of adiponectin in folliculogenesis.
12. Omentin
The concentration of Omentin in FF was found to be positively correlated with 
BMI, higher in obese patients compared to the normal weight patients. They also 
point out that the omentin may possibly be controlled by means of inflammation, 
because the expression of omentin altered in inflammatory conditions [18].
13. Oxidative stress
ROS is necessary to maintain the normal female reproductive physiology, it is 
involved in the oocyte maturation, corpus luteum apoptosis as well as embryonic 
development process. The release of mature oocyte depends on the expansion of 
cumulus oocyte complex (COC), where the reactive oxygen species (ROS) function as 
critical modulator of inflammatory reaction. The exposure of ROS may lead to under 
transformative alterations of epithelial cells in the ovary and fallopian tubes [10].
14. Tumor necrosis factor-α
It has a significant role in the process of ovulation as well as to excrete out the 
damaged corpous luteum from the ovarian tissue. It works by the ligand gated 
receptors, TNFR-I and TNFR-II [10, 19]. It is also linked with the various pathological 
conditions when its level elevated. It is also reported that the infertile women with 
PCOS reported to have higher free fatty acids and blood serum level of TNF-α when 
compared with the healthy patients. Oxidative stressed cells also found to release 
higher levels of TNF-α than the normal ovarian epithelial cells which results in an 
autocrine surge of TNF-α mRNA as well as in the form of expression in other pro-
inflammatory cytokines, chemokines, and angiogenic factors [10, 20, 21].
15. Interleukins
Interleukin-15 is an important interleukin which is negatively associated with 
the oocyte maturation. It belongs to the cytokines family having four α-helix 
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bundle, i.e. pleiotropic glycoprotein. It was reported to be higher in women with an 
unsuccessful assisted reproductive techniques outcomes (median value 1.4 pg./ml) 
than of the women those succeeded the clinical pregnancy (median value 0.8 pg./ml) 
[22]. The IL-6 is a regulator of cumulus cell-oocyte complex (COC) expansion and 
responsible for the quality of murine oocyte during the in-vitro fertilization.
16. Matrix metalloproteinases
The another factor which has been found to be involved in follicular develop-
ment as well as in the ovulation process are Matrix metalloproteinases (MMPs). 
The matrix metalloproteinases activities regulated by the specific tissue 
inhibitors called metalloproteinases (TIMPs) and endogenous inhibitors. The 
balance of both these is very essential for their activity and to maintain the 
normal ovarian physiology. It is well noticed that the MMP-2 and MMP-9 level 
increased during and before the 3 hours of ovulation if compared to 20–22 hour 
before the ovulation. Augmented level of MMP-9 also postulated in the PCOS 
pathophysiology and is also linked with progression and etiological to many 
other ailments such as cystic fibrosis, asthma, ulcerative colitis, cardiovascular 
disorders, atherosclerosis, etc. [23, 24].
17. Peroxisome proliferator-activated receptor gamma
The Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) is established 
to have an ability to prevent the expression of various signaling molecules also 
regulates the levels of prostaglandins through regulation of cyclooxygenase-2 and 
differentiation of immune cells especially those which are a part of inflammation. 
Thereby controls ovarian function, fertilization, and ovulation. Its proinflammatory 
activity is linked to the formation of prostaglandin E by downregulation of COX-2 
mRNA of granulosa cells whereas it is upregulated twice in PCOS [25]. It is also 
being proven that the PPAR-γ controls genes responsible for expression of TNF-
alpha and Interleukins along with others. The study is supported by use of PPAR-γ 
agonist which affected the functioning of ovaries by involving signal transduction 
of insulin and IGF [20].
18. Chemokines
Earlier study reported the expression of chemokine receptor-2 (C-C motif) 
(CCR2) in the human ovarian cumulus-oocyte complexes, theca cells, preovulatory 
follicles and in feline ovarian follicle walls. This receptor is believed to be involved in 
folliculogenesis and determines the reproductive lifespan of female [25] (Figure 1).
19. Conclusions
Inflammation is believed to be involved in triggering the process of ovulation. 
There are several factors, genes, receptors, proinflammatory mediators playing 
important but diverse role in ovulation. The extent of their role and intensity 
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